AKT1 and cancer: Fortunately, our results showed that the tumor-related pathways, Regulation of actin cytoskeleton, MAPK signaling pathway, ECM–receptor interaction, Proteoglycans in cancer, Focal adhesion, PI3K-Akt signaling pathway and Pathway in cancer, were inhibited by 6-TG.